Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

4.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Telomeres and Telomerase02:41

Telomeres and Telomerase

28.2K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
28.2K
Lineage Commitment01:21

Lineage Commitment

4.5K
Commitment is the  process whereby stem cells:
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical decision support in hematological malignancies using a case-grounded AI agent.

Nature medicine·2026
Same author

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Nature·2026
Same author

Nociceptor neurons suppress antitumor immunity in breast cancer.

Research square·2026
Same author

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

Nature communications·2026
Same author

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

Nature cell biology·2026
Same author

Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

Blood·2026

Related Experiment Video

Updated: Mar 18, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K

Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.

Zhenyu Ju1, Hong Jiang, Maike Jaworski

  • 1Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, 30625 Hannover, Germany.

Nature Medicine
|May 9, 2007
PubMed
Summary

Telomere dysfunction in aging mice creates a defective bone marrow environment that impairs blood stem cell function. This environmental damage affects B cell production and limits the success of stem cell transplantation.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.8K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.6K

Related Experiment Videos

Last Updated: Mar 18, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.8K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.6K

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Aging Research

Background:

  • Cell-intrinsic checkpoints limit primary cell proliferation due to telomere dysfunction.
  • The impact of telomere dysfunction on cell-extrinsic factors affecting stem cell function and organ homeostasis remains unclear.

Purpose of the Study:

  • To investigate whether telomere dysfunction contributes to cell-extrinsic alterations impacting hematopoietic stem cell (HSC) function and organ homeostasis.
  • To elucidate the mechanisms by which telomere dysfunction affects the hematopoietic environment and its consequences for aging and transplantation.

Main Methods:

  • Utilized aging telomerase knockout (Terc(-/-)) mice to study the effects of telomere dysfunction.
  • Assessed B lymphopoiesis, myeloid proliferation, and HSC engraftment in aging Terc(-/-) mice.
  • Analyzed bone marrow stromal cells for telomere length and mesenchymal progenitor cell function.
  • Measured plasma cytokine levels, focusing on granulocyte colony-stimulating factor (G-CSF).
  • Administered G-CSF to wild-type mice and inhibited G-CSF in aged Terc(-/-) mice to assess functional impacts.

Main Results:

  • Telomere dysfunction in aging Terc(-/-) mice led to a defective hematopoietic environment, impairing B lymphopoiesis and increasing myeloid proliferation.
  • This dysfunctional environment reduced the engraftment capacity of transplanted wild-type HSCs.
  • Age-dependent telomere shortening in bone marrow stromal cells correlated with impaired mesenchymal progenitor function and reduced HSC maintenance.
  • Elevated G-CSF levels were observed in aging mice, and G-CSF administration mimicked B lymphopoiesis defects and impaired HSC engraftment.

Conclusions:

  • Telomere dysfunction induces cell-extrinsic alterations in the hematopoietic environment, impacting organismal aging.
  • These environmental changes negatively affect HSC function and limit the efficacy of cell transplantation therapies.
  • Targeting cytokines like G-CSF may offer therapeutic strategies to improve HSC engraftment and address age-related hematopoietic decline.